• VACCIN MALADIE DE NEWCASTLE

    AVAILABLE TECHNOLOGY I Vaccine – Farms
  • NODIA

    AVAILABLE TECHNOLOGY I Diabete – Inhibitor
  • DIVINS

    START-UP I Aneurysms
  • CELDI

    MARKETED TECHNOLOGY I Reaction – Solid – Fluid – Gaz
  • CATA PEMFC

    AVAILABLE TECHNOLOGY | Catalysts – Battery – Electrolysers
  • SILEXE

    MARKETED TECHNOLOGY I Strategic metal – Recycle
  • ION EX

    MARKETED TECHNOLOGY I  Pollution – Anionic contaminants
  • Ultrasensitive Magnetic Sensor

    AVAILABLE TECHNOLOGY I Electrical safety
  • DEPOTHS

    AVAILABLE TECHNOLOGY I Desalination water
  • GREEN TECH COMPOSITE

    AVAILABLE TECHNOLOGY I Epoxy mixtures bio-sourced
  • naNOcomp

    AVAILABLE TECHNOLOGY I Controlled delivery of NO
  • MAGNETIC GAZ SENSOR

    AVAILABLE TECHNOLOGY I Gaz sensor
  • TerriStories®

    MARKETED TECHNOLOGY I Simulation game
  • STAR TRACKER

    AVAILABLE TECHNOLOGY I Star sensor – Nanosatellite
  • SETES

    AVAILABLE TECHNOLOGY I Spectroscopy – Biosensors
  • P42

    AVAILABLE TECHNOLOGY I Peptide – Huntington
  • EPIDROP

    AVAILABLE TECHNOLOGY I Circulating tumor cells
  • TELE-MOUV

    MARKETED TECHNOLOGY I Chronic diseases – Telemedicine
  • AUTOMATIC VARROA COUNTER

    AVAILABLE TECHNOLOGY | Precision apiculture – Artificial intelligence – Varroa destructor
  • EHRLICHIOSIS VACCINE

    AVAILABLE TECHNOLOGY I Vaccine – Animal health
  • HRM

    AVAILABLE TECHNOLOGY I Animal health – Molecular diagnostics
  • BLISS / Adapt2Pulv

    AVAILABLE TECHNOLOGY | Spraying – Treatment – Spreading
  • HPCG

    MARKETED TECHNOLOGY I Genetic variations
  • ALPHA-CENTAURI

    AVAILABLE TECHNOLOGY | Innate immunity – Infectious diseases – Cancer
  • PL-VAC

    AVAILABLE TECHNOLOGY | Leishmanioses – Secretomes – Multi-epitope peptide vaccine
  • CAPDCM

    AVAILABLE TECHNOLOGY | Microfluidics – Chemoattraction – Drug release
  • RESIST-655

    AVAILABLE TECHNOLOGY | Bacterial resistance to antibiotics – Gram-negative bacteria – Heterocyclic compounds
  • RESIST-430

    AVAILABLE TECHNOLOGY | Bacterial resistance to antibiotics – Gram-negative bacteria – Gamma-peptides
  • PERSPECTYV

    AVAILABLE TECHNOLOGY | Facioscapulohumeral dystrophy – Personalized treatment –
  • 3D-CELLS

    AVAILABLE TECHNOLOGY | Sub-micron fiber matrix – Electrospinning – 3D cell culture
  • MSC 2.0

    AVAILABLE TECHNOLOGY | Myocardial infarction – Human mesenchymal stem cells – Innovative cell therapy
  • INNOVAC PPR

    AVAILABLE TECHNOLOGY | “Peste des Petits Ruminants” (PPR, sheep and goat plague) – Innovative vaccines – DIVA (“Differentiating Infected from Vaccinated Animals”)
  • TARMAK

    AVAILABLE TECHNOLOGY | Therapeutic combination – Synergy effect in pharmacology – Prostate cancer
  • PSYMAGES

    TECHNOLOGIE AVAILABLE | Iconography – Mental imaging – Education and therapeutic compliance
  • LRAs

    AVAILABLE TECHNOLOGY | HIV – Shock & Kill Strategy – LRAs
  • TESOVIR

    AVAILABLE TECHNOLOGY | HIV Reservoir – Biomarkers – mAb
  • GeniaTer-CMT1A

    MARKETED TECHNOLOGY | Gene therapy – Nontraumatic intraneural injection – CMT1A
  • TIX001

    AVAILABLE TECHNOLOGY | Prevention of the toxicity of DNA-damaging anti-cancer agents – Chemotherapy and radiotherapy – Improvement of anti-cancer treatment efficacy
  • SPIMA

    AVAILABLE TECHNOLOGY | Stapled Peptides – Inflammatory diseases – Oncology
  • LipoSTAR

    AVAILABLE TECHNOLOGY | Lipophenols – Carbonyl and oxidative stresses – MMP-9
  • DOCK 5

    AVAILABLE TECHNOLOGY | Osteolytic diseases – Dock5 – NCE
  • IMIQUALINES

    AVAILABLE TECHNOLOGY | cancer – imiqualines
  • NANO4SCHIZO

    AVAILABLE TECHNOLOGY | Nanobody – Schizophrenia – mGlu2
  • ACUSURGICAL

    START-UP I AxLR Project I Robotic assistance retina surgery
  • BENCHRANKING

    START-UP I AxLR Project I Measure indicator attractiveness outdoor hotel offer
  • BIONOMEEX

    START-UP I AxLR Project I IA science
  • GEOSOTECH

    START-UP I AxLR Project I Electronics, marine and terrestrial fauna monitoring
  • REEFPULSE

    MARKETED TECHNOLOGY | Ecological status and functioning of coral reefs – Eco-acoustics – Artificial Intelligence
  • HTLV-1

    AVAILABLE TECHNOLOGY | Rare disease – Adult T-cell Leukemia (ATL) – HTLV-1
English